DUODENOSCOPES MARKET ANALYSIS

Market Challenges And Opportunities

Global Duodenoscopes Market – Drivers

Increasing Prevalence Of Gastrointestinal, Liver, and Pancreatic Diseases

Increasing prevalence of gastrointestinal, liver, and pancreatic diseases is expected to drive the global duodenoscopes market growth over the forecast period. For instance, according to the article published by National Libarary of Medicine Journal, in August 2021, There were 2,814,972.3 incident cases of acute pancreatitis occurred in 2020 globally; 1,273,955.2 in women and 1,541,017.1  in men. The global age-standardized incidence rate declined from 37.9/100,000 to 34.8/100,000 during 1990–2019, an annual decrease of 8.4% (5.9–10.4%).

Increasing Technological Advancements

increasing technological advancements  is expected to drive the market growth. For instance, according to the study published by the World Health Orgnization, in October 2020, U.S. FDA announced that it had approved the disposable duodenoscope EXALT Model D technological advance product, manufactured by Boston Scientific, a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices in U.S.

Global Duodenoscopes Market: Restraint

Stringent Government Regulations For Manufacturing and Marketing

Stringent Government Regulations For Manufacturing and Marketing are the major factors confining the use of duodenoscopes. For instance on January 10, 2023, the FDA issued warning letters to manufacturers of duodenoscopes in the U.S. including Fujifilm Medical Systems USA, Inc., Olympus Medical Systems Corporation, and Pentax of America thatfailed to provide sufficient data to address postmarket surveillance studies requirements under Section 522 of the Federal Food, Drug, and Cosmetic Act.

Stringent government regulations for devices manufacturing and marketing